Surface Modification with Lactadherin Augments the Attachment of Sonazoid Microbubbles to Glycoprotein IIb/IIIa

Kentaro Otani, Atsunori Kamiya, Takahiro Miyazaki, Ayumi Koga, Ayako Inatomi, Mariko Harada-Shiba

Research output: Contribution to journalArticle

Abstract

Arginine–glycine–aspartate (RGD)-carrying microbubbles (MBs) have been utilized as a specific contrast agent for glycoprotein IIb/IIIa (α IIb β 3 integrin)-expressing activated platelets in ultrasound molecular imaging. Recently, we found that surface modification with lactadherin provides the RGD motif on the surface of phosphatidylserine-containing clinically available MBs, Sonazoid. Here, we examined the potential of lactadherin-bearing Sonazoid MBs to be targeted MBs for glycoprotein IIb/IIIa using the custom-designed in vitro settings with recombinant α IIb β 3 integrin, activated platelets or erythrocyte-rich human clots. By modification of the surface with lactadherin, a large number of Sonazoid MBs were attached to the α IIb β 3 integrin-coated and platelet-immobilized plate. Additionally, the video intensity of clots after incubation with lactadherin-bearing Sonazoid MBs was significantly higher than that with unmodified Sonazoid MBs, implying the number of attached Sonazoid MBs was increased by the modification with lactadherin. Our results suggest that the lactadherin-bearing Sonazoid MBs have the potential to be thrombus-targeted MBs.

Original languageEnglish
JournalUltrasound in Medicine and Biology
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Microbubbles
Platelet Glycoprotein GPIIb-IIIa Complex
platelets
attachment
erythrocytes
Integrins
Blood Platelets
Sonazoid
Molecular Imaging
Phosphatidylserines
Contrast Media
Ultrasonography
Thrombosis
Erythrocytes

Keywords

  • Glycoprotein IIb/IIIa
  • Microbubble
  • Platelets
  • Thrombus
  • Ultrasound molecular imaging

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Biophysics
  • Acoustics and Ultrasonics

Cite this

Surface Modification with Lactadherin Augments the Attachment of Sonazoid Microbubbles to Glycoprotein IIb/IIIa. / Otani, Kentaro; Kamiya, Atsunori; Miyazaki, Takahiro; Koga, Ayumi; Inatomi, Ayako; Harada-Shiba, Mariko.

In: Ultrasound in Medicine and Biology, 01.01.2019.

Research output: Contribution to journalArticle

@article{a9c43546038743f083822ff7942ff4dc,
title = "Surface Modification with Lactadherin Augments the Attachment of Sonazoid Microbubbles to Glycoprotein IIb/IIIa",
abstract = "Arginine–glycine–aspartate (RGD)-carrying microbubbles (MBs) have been utilized as a specific contrast agent for glycoprotein IIb/IIIa (α IIb β 3 integrin)-expressing activated platelets in ultrasound molecular imaging. Recently, we found that surface modification with lactadherin provides the RGD motif on the surface of phosphatidylserine-containing clinically available MBs, Sonazoid. Here, we examined the potential of lactadherin-bearing Sonazoid MBs to be targeted MBs for glycoprotein IIb/IIIa using the custom-designed in vitro settings with recombinant α IIb β 3 integrin, activated platelets or erythrocyte-rich human clots. By modification of the surface with lactadherin, a large number of Sonazoid MBs were attached to the α IIb β 3 integrin-coated and platelet-immobilized plate. Additionally, the video intensity of clots after incubation with lactadherin-bearing Sonazoid MBs was significantly higher than that with unmodified Sonazoid MBs, implying the number of attached Sonazoid MBs was increased by the modification with lactadherin. Our results suggest that the lactadherin-bearing Sonazoid MBs have the potential to be thrombus-targeted MBs.",
keywords = "Glycoprotein IIb/IIIa, Microbubble, Platelets, Thrombus, Ultrasound molecular imaging",
author = "Kentaro Otani and Atsunori Kamiya and Takahiro Miyazaki and Ayumi Koga and Ayako Inatomi and Mariko Harada-Shiba",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ultrasmedbio.2019.01.022",
language = "English",
journal = "Ultrasound in Medicine and Biology",
issn = "0301-5629",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Surface Modification with Lactadherin Augments the Attachment of Sonazoid Microbubbles to Glycoprotein IIb/IIIa

AU - Otani, Kentaro

AU - Kamiya, Atsunori

AU - Miyazaki, Takahiro

AU - Koga, Ayumi

AU - Inatomi, Ayako

AU - Harada-Shiba, Mariko

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Arginine–glycine–aspartate (RGD)-carrying microbubbles (MBs) have been utilized as a specific contrast agent for glycoprotein IIb/IIIa (α IIb β 3 integrin)-expressing activated platelets in ultrasound molecular imaging. Recently, we found that surface modification with lactadherin provides the RGD motif on the surface of phosphatidylserine-containing clinically available MBs, Sonazoid. Here, we examined the potential of lactadherin-bearing Sonazoid MBs to be targeted MBs for glycoprotein IIb/IIIa using the custom-designed in vitro settings with recombinant α IIb β 3 integrin, activated platelets or erythrocyte-rich human clots. By modification of the surface with lactadherin, a large number of Sonazoid MBs were attached to the α IIb β 3 integrin-coated and platelet-immobilized plate. Additionally, the video intensity of clots after incubation with lactadherin-bearing Sonazoid MBs was significantly higher than that with unmodified Sonazoid MBs, implying the number of attached Sonazoid MBs was increased by the modification with lactadherin. Our results suggest that the lactadherin-bearing Sonazoid MBs have the potential to be thrombus-targeted MBs.

AB - Arginine–glycine–aspartate (RGD)-carrying microbubbles (MBs) have been utilized as a specific contrast agent for glycoprotein IIb/IIIa (α IIb β 3 integrin)-expressing activated platelets in ultrasound molecular imaging. Recently, we found that surface modification with lactadherin provides the RGD motif on the surface of phosphatidylserine-containing clinically available MBs, Sonazoid. Here, we examined the potential of lactadherin-bearing Sonazoid MBs to be targeted MBs for glycoprotein IIb/IIIa using the custom-designed in vitro settings with recombinant α IIb β 3 integrin, activated platelets or erythrocyte-rich human clots. By modification of the surface with lactadherin, a large number of Sonazoid MBs were attached to the α IIb β 3 integrin-coated and platelet-immobilized plate. Additionally, the video intensity of clots after incubation with lactadherin-bearing Sonazoid MBs was significantly higher than that with unmodified Sonazoid MBs, implying the number of attached Sonazoid MBs was increased by the modification with lactadherin. Our results suggest that the lactadherin-bearing Sonazoid MBs have the potential to be thrombus-targeted MBs.

KW - Glycoprotein IIb/IIIa

KW - Microbubble

KW - Platelets

KW - Thrombus

KW - Ultrasound molecular imaging

UR - http://www.scopus.com/inward/record.url?scp=85062455437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062455437&partnerID=8YFLogxK

U2 - 10.1016/j.ultrasmedbio.2019.01.022

DO - 10.1016/j.ultrasmedbio.2019.01.022

M3 - Article

C2 - 30857759

AN - SCOPUS:85062455437

JO - Ultrasound in Medicine and Biology

JF - Ultrasound in Medicine and Biology

SN - 0301-5629

ER -